Drug dosage in renal impairment: variation in recommendations

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1490, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjust valganciclovir dosage in renal impairment

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Ximelagatran, melagatran dosage in severe renal impairment

By  

Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A Concept for Pharmacokinetic- Pharmacodynamic Dosage Adjustment in Renal Impairment: The Case of Aminoglycosides

By Czock D.  

Clinical Pharmacokinetics, Vol. 38, Iss. 4, 2000-04 ,pp. : 367-375

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

By Kearney Brian P.   Yale Kitty   Shah Jaymin   Zhong Lijie   Flaherty John F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1115-1124

Adis International

Access to resources Recommend Favorite

New dosage recommendations/contraindications for simvastatin

By  

Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite